You're listening to this week in cardiology from the heart.org on medscape.

You can now access the latest in medical news on your Amazon Alexa enabled device.

Join me, Perry Wilson, every weekday morning for Medscape Medical Minute,

where I highlight the top medical stories of the day.

To add Medscape Medical Minute to your flash briefing, search for Medscape Medical

Minute on Amazon and click enable. Or open the Amazon Alexa app, go to Skills, search for Medscape

Medical Minute and click enable. Then say,

Alexa, what's the news or Alexa, what's my flash briefing? I hope you'll join us.

Hi everyone, this is John Mandrola from the Heart.org Medscape Cardiology and this is this week in

cardiology for October 30th, 2020.

This week, COVID, the Remdessefere approval, the athletic heart in COVID,

Treponin's silliness, and a potential new MRA drug.

First to COVID update. It is worse. Cases are increasing in Europe and in the U.S.

I wrote a blog post in March that this virus would not be contained that is outside of island nations.

I was right.

Testing and contact tracing in a rambunctious and free country such as America is utter folly. Two facts. This is a coronavirus. These are the

viruses that cause colds. They are super infectious. Also making it impossible to stop is that the majority of people who get infected

don't get that sick. One quick comment before I go on to the science. Well, I don't have a degree in public health. I am pretty sure that the practice of public

health is about more than counting virus cases and hospitalization. The pandemics of effects on society are heterogeneous. It seems to me then, so

ought the interventions be heterogeneous. For instance, I stand in awe of the stupidity of our city's policy of having public schools closed

while the private schools are open.

I mean, since education is literally one of the most important determinants of health,

...